← Leaderboards
Benedetta Nicolis Di Robilant
Dorian Therapeutics, Inc.
$335,648
Attributed
$335,648
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$335,648 · 1
By mechanism
R43$335,648 · 1
Top collaborators
No co-investigators on record.
Most similar at Dorian Therapeutics, Inc.
Same institution · by research overlap
- Maddalena Adorno$4,178,124
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAmericanAnimal ModelAntigensBaseCancer CellCar T Cell TherapyCd19 GeneCell AgeCell AgingCell LineCell PhysiologyCellsCell StromaChimeric Antigen Receptor T CellsChromatinCoculture TechniquesCytokine Release SyndromeDeubiquitinating EnzymeDna CassetteDoxorubicinEarly Phase Clinical TrialEffector T Cell3-Dimensional